Anaptysbio (ANAB) Net Equity Issued and Repurchased (2016 - 2026)
Anaptysbio (ANAB) posted Net Equity Issued and Repurchased of $14.02 million for Q1 2026, compared with -$4.13 million a year earlier and up 58.8% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Net Equity Issued and Repurchased at Anaptysbio was -$36.21 million; for FY2025, it came in at -$54.37 million.
- In prior years, Anaptysbio's Net Equity Issued and Repurchased was $100.39 million in FY2024, -$47.53 million in FY2023, $11.83 million in FY2022 (+363.3%) and $2.55 million in FY2021 (+414.7%).
- The Q1 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q3 2024.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $8.83 million (Q4 2025), -$9.38 million (Q3 2025) and -$49.68 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Anaptysbio | 1.40 Bn | 1.40 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 14.02 Mn |
| Dec 31, 2025 | 8.83 Mn |
| Sep 30, 2025 | -9.38 Mn |
| Jun 30, 2025 | -49.68 Mn |
| Mar 31, 2025 | -4.13 Mn |
| Dec 31, 2024 | 99,000.00 |
| Sep 30, 2024 | 98.50 Mn |
| Jun 30, 2024 | 979,000.00 |
| Mar 31, 2024 | 811,000.00 |
| Dec 31, 2023 | 264,000.00 |
| Sep 30, 2023 | 160,000.00 |
| Jun 30, 2023 | -11.69 Mn |
| Mar 31, 2023 | -36.26 Mn |
| Dec 31, 2022 | 3.42 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 865,000.00 |
| Mar 31, 2022 | 4.84 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 241,000.00 |
| Jun 30, 2021 | 554,000.00 |
API Access
Anaptysbio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();